🇺🇸 FDA
Pipeline program

Clopidogrel

OPERA 1.0 - AEEI

Approved small_molecule completed

Quick answer

Clopidogrel for Coronary Artery Disease is a Approved program (small_molecule) at Evidence Based Cataract Study Group with 1 ClinicalTrials.gov record(s).

Program details

Company
Evidence Based Cataract Study Group
Indication
Coronary Artery Disease
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials